60 likes | 304 Views
As per the analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market. Get Full Details at: http://www.researchbeam.com/global-generic-drugs-2014-2018-market
E N D
Global Generic Drugs Market 2014-2018 Published by : Technavio Date : March 2014 Page : 95 Category: Pharmaceuticals http://www.researchbeam.com
Report Overview Research Beam adds a report titled “Global Generic Drugs Market 2014-2018” that provides detailed information of the Generic Drugs Market. The report is an excellent piece of study for investors who are looking towards the market. As per the analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market. Detailed Info Available at: http://www.researchbeam.com/global-generic-drugs-2014-2018-market
Report Overview The Global Generic Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Generic Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space include Actavisplc, Mylan Inc., Novartis International AG (Sandoz), STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd. Other vendors mentioned in the report are 3SBio Inc., Amgen Inc., Apotex Inc., AstraZeneca plc, AurobindoPharma Ltd., Baxter International Inc., Berlin-Chemie AG, Biocon Ltd., Biogen Idec Inc., BoehringerIngelheim GmbH, Celltrion Inc., Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., etc.
Report Overview Key questions answered in this report: What will the market size and growth rate be in 2018? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of each of these key vendors? You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report. Enquire About Report: http://www.researchbeam.com/global-generic-drugs-2014-2018-market/enquire-about-report
Table of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Generic Drugs Market in the US 06.3.1 Market Size and Forecast 06.4 Generic Drugs Market in Europe 06.4.1 Market Size and Forecast 06.5 Generic Drugs Market in Germany 06.5.1 Market Size and Forecast
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/global-generic-drugs-2014-2018-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com